Noctrix Health is a medical device company focused on developing non-invasive solutions for sleep disorders, particularly those related to the autonomic nervous system. Their products aim to improve sleep quality without the need for pharmaceuticals or surgery.

Jonathan Charlesworth

Noctrix Health

Noctrix Health is pioneering the next-generation of therapeutic wearables that empower patients to take control of their chronic medical conditions. We aim to provide a powerful, efficacious and cost-effective alternative to pharmaceutical therapies.

Bolt

Social Starts

Joyance Partners

Life Science Angels

OrbiMed

Treo Ventures

LivaNova

Noctrix Health, Inc.

Quality sleep can be life changing. 

That's why 𝐍𝐨𝐜𝐭𝐫𝐢𝐱 𝐇𝐞𝐚𝐥𝐭𝐡 is committed to working with patients and providers to advance treatments and improve the quality of life for people suffering from Restless Legs Syndrome (RLS).

Every day, millions of people are affected by sleep disorders like RLS. These conditions not only affect sleep quality but also have a massive impact on the day-to-day lives of these individuals. Tech advancements are opening new possibilities for better sleep, which might just make our mornings feel more rested and our days seem more refreshed.

Here is just one of many inspiring reactions by a clinical study participant to the latest technology that Noctrix Health is bringing to the RLS community: "𝐴𝑚𝑎𝑧𝑖𝑛𝑔𝑙𝑦 𝑡ℎ𝑖𝑠 𝑖𝑠 𝑡ℎ𝑒 𝑓𝑖𝑟𝑠𝑡 𝑡𝑖𝑚𝑒 𝑖𝑛 𝑑𝑒𝑐𝑎𝑑𝑒𝑠 𝐼 𝑓𝑒𝑙𝑙 𝑏𝑎𝑐𝑘 𝑎𝑠𝑙𝑒𝑒𝑝. 𝐻𝑎𝑣𝑖𝑛𝑔 𝑡ℎ𝑒 𝑑𝑒𝑣𝑖𝑐𝑒 ℎ𝑎𝑠 𝑏𝑒𝑒𝑛 𝑎 𝑚𝑖𝑟𝑎𝑐𝑙𝑒."

To learn more about Nidra therapy for RLS, please visit 𝐰𝐰𝐰.𝐧𝐢𝐝𝐫𝐚𝐫𝐥𝐬.𝐜𝐨𝐦.

Wishing you restful nights on World Sleep Day 2024!

𝑁𝑖𝑑𝑟𝑎 𝑖𝑠 𝑑𝑟𝑢𝑔-𝑓𝑟𝑒𝑒 𝑎𝑛𝑑 𝑐𝑙𝑖𝑛𝑖𝑐𝑎𝑙𝑙𝑦 𝑝𝑟𝑜𝑣𝑒𝑛 𝑡𝑜 𝑟𝑒𝑑𝑢𝑐𝑒 𝑠𝑦𝑚𝑝𝑡𝑜𝑚𝑠 𝑖𝑛 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑤𝑖𝑡ℎ 𝑝𝑟𝑖𝑚𝑎𝑟𝑦, 𝑚𝑜𝑑𝑒𝑟𝑎𝑡𝑒-𝑠𝑒𝑣𝑒𝑟𝑒 𝑅𝐿𝑆 𝑡ℎ𝑎𝑡 𝑎𝑟𝑒𝑛'𝑡 𝑠𝑎𝑡𝑖𝑠𝑓𝑖𝑒𝑑 𝑤𝑖𝑡ℎ 𝑡ℎ𝑒𝑖𝑟 𝑐𝑢𝑟𝑟𝑒𝑛𝑡 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡.

Exciting news to start the year! Noctrix Health has successfully closed a $40M Series C funding round to advance the commercialization of Nidra TOMAC therapy. Nidra is the first and only approved option for millions of patients suffering from RLS that is refractory to medications. 

#meddevice #wearabletechnology #neuromodulation #sleephealth  #sleepdisorders #rls #wearabledevices #wearables 
 
https://lnkd.in/gfNB6eWF

🌟 Exciting Opportunity for Physical Therapists and Polysomnographic Technologists! 🌙

Noctrix is on the lookout for 1099 Physical Therapists or Polysomnographic Technologists interested in part-time roles in the Kansas City, Missouri, and Columbus, Ohio areas. We're introducing Nidra, an FDA-cleared, prescription wearable device designed to treat Restless Legs Syndrome. Learn more at https://nidrarls.com/.

Utilizing TOMAC technology, Nidra provides consistent neurostimulation therapy tailored to each leg during a 1-hour personalization session. As we expand, we need your support in these markets to help get patients started on therapy. If you love making a difference in the lives of those with RLS and want to know more about the product, data, and patient titration requirements, please reach out directly.

Join us in making a positive impact! 💼🌐 #JobOpportunity #HealthTech #RLSTreatment #nidra #TOMAC #RLS

🌟 Exciting News Alert! 🌟 Another milestone achieved by Nidra TOMAC Therapy and Noctrix Health!

📚 We're thrilled to share that our opioid reduction clinical trial results have been featured in the BMC Neurology journal! 🧠💡 

This is the first evidence showing that TOMAC may help reduce medication use for RLS, specifically for opioids.

Nidra TOMAC Therapy, a prescription device, is designed to treat symptoms of moderate-severe Restless Legs Syndrome (RLS) and enhance sleep quality in patients refractory to medication. 🌙✨ The therapy involves a pair of devices worn on the lower legs, stimulating the peroneal nerves bilaterally. This produces tonic, sustained muscle activation that is compatible with sleep to suppress symptoms of RLS.

BMC Neurology Published: 21 November 2023 volume 23, Article number: 415 (2023)

#nidra #RLS #TOMAC #nidrarls

🚀 Noctrix Health shines on the podium at World Sleep 2023 in Brazil! 🇧🇷

Kudos to our experts, Jonathan Charlesworth and Stephanie Rigot, DPT, PhD, for showcasing the science behind Nidra™ TOMAC Therapy on the global stage last week. 🌎🌙
#worldsleep2023 #nidra #RLS #TOMAC #nidrarls

Happy Sleep Technologists Appreciation Week 2023!  

Join us in celebrating all sleep technologists who dedicate their time to helping those living with sleep disorders!  

A special shout out to the sleep technologists who worked with us on our clinical trials that helped bring Nidra TOMAC therapy to market! 

#STAW2023 #RLS #sleepmedicine #nidra #TOMAC

Join us in Rio de Janeiro for World Sleep 2023! Discover the latest scientific breakthroughs presented by our experts, Jonathan Charlesworth and Stephanie Rigot, DPT, PhD. See you there!
#sleepmedicine #worldsleep2023 #nidra #TOMAC #RLS

📢 Hot off the press! A new study in Neurology and Therapy confirms the high cost-effectiveness of TOMAC therapy. 🚀 This is another compelling reason to treat severe RLS and provide millions of patients with the relief they truly deserve.


https://lnkd.in/g4qFKZfJ

Exciting news! We're on the lookout for a passionate Director of Customer Care to lead our Patient Concierge and Therapy Support teams as we embark on a mission to provide much-needed relief to those battling Restless Leg Syndrome. If you're ready to make a meaningful impact and have experience with Salesforce, we want to hear from you – let's revolutionize patient care together!

Metric
Company Name	Noctrix Health
Symbol
MSH ID	COM:NOCTRIXHEALTH
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Devices
Country	US
Stage
Employee Count	40
Website	noctrixhealth.com
LinkedIn	noctrix-health
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:NOCTRIXHEALTH

Noctrix Health

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue